NAM-based analysis of contaminant short-term organ toxicity in HepaRG and RPTEC/TERT1 cells

Kristina Jochum1, Andrea Miccoli2, Cornelia Sommersdorf3

  • 1German Federal Institute for Risk Assessment, Department of Pesticides Safety, Berlin, Germany.

Toxicology
|March 7, 2025
PubMed

Insights

New Approach Methodologies (NAMs) show promise for replacing animal testing in food contaminant risk assessment. This study validated a NAM protocol using omics and cell cultures, demonstrating its applicability across diverse chemical and natural toxins.

Area of Science:

  • Toxicology
  • In vitro toxicology
  • Omics technologies

Background:

  • New Approach Methodologies (NAMs) offer alternatives to animal testing for chemical risk assessment.
  • Applicability of NAMs across diverse substance classes, including food contaminants, is crucial for regulatory acceptance.
  • Food contaminants encompass synthetic chemicals (e.g., PFOS, PFOA) and natural toxins (e.g., mycotoxins, pyrrolizidine alkaloids).

Purpose of the Study:

  • To evaluate the applicability of a NAM-based testing protocol for assessing the toxicity of various food contaminants.
  • To compare the responses of HepaRG (liver) and RPTEC/TERT1 (kidney) cell lines to different contaminants.
  • To investigate the utility of omics analyses and pathway analysis for predicting toxicological effects.

Main Methods:

  • Utilized HepaRG and RPTEC/TERT1 cell lines exposed to five known contaminants (PFOS, PFOA, Aflatoxin B1, lasiocarpine, cadmium chloride) at non-cytotoxic concentrations.
  • Employed a NAM protocol including marker protein analysis for cellular functions and targeted transcriptomics.
  • Conducted bioinformatics pathway analysis to interpret omics data and compared results with in vivo data.

Main Results:

  • Protein analysis revealed pathway alterations in HepaRG cells, with fewer effects observed in RPTEC/TERT1 cells.
  • Lasiocarpine exhibited the strongest transcriptional impact in HepaRG cells.
  • Significant differences in cell line responses were noted; RPTEC/TERT1 cells were less suitable for detecting hepatically metabolized toxins like lasiocarpine and Aflatoxin B1.

Conclusions:

  • The validated NAM protocol is applicable across different substance classes, supporting its use in risk assessment.
  • Pathway analysis enables mechanism-based toxicity prediction, independent of the target organ.
  • Integrated omics approaches provide comprehensive insights into compound-induced effects, advancing toxicological assessments.